Literature DB >> 16198602

The logical choice of muscles for the needle-EMG evaluation of lumbosacral radiculopathy.

Israel Yaar1.   

Abstract

The objective of this study was to find the theoretically smallest subsets of muscles for needle-EMG (nEMG) screening of lumbosacral radiculopathies that ascertain that each root and its adjacent roots are represented by at least two muscles each, innervated by those roots via different peripheral nerves. A 23 and a 30 muscles muscle-sets and their myotomal innervation where derived from the literature, and rearranged into 15 and 19 unique muscle-groups by root and peripheral nerve innervation. All 2(15) and 2(19) subset combinations thereof were respectively identified. The criteria above were computed for each subset and the smallest subsets that qualified were retained. The number of muscles sampled per damaged root and the number of muscles sampled per adjacent roots in compliance with the objective above were computed. The smallest subsets satisfying the objective above were of 6, 7 and 9 muscles each, and are enumerated in . From these tables, each electromyographer may choose a set that best suits him, confident of its diagnostic parameters, while inflicting the least pain onto his patients, utilizing the shortest possible procedure, concluding a screen of all the roots at once, a screen that best differentiate between normal and damaged roots, and in most cases adequate for reaching the final diagnosis. Moreover, when needed, each set may be the basis for a more extensive workup.

Entities:  

Mesh:

Year:  2005        PMID: 16198602     DOI: 10.1016/j.jelekin.2005.07.007

Source DB:  PubMed          Journal:  J Electromyogr Kinesiol        ISSN: 1050-6411            Impact factor:   2.368


  1 in total

1.  Electrodiagnosis support system for localizing neural injury in an upper limb.

Authors:  Hanjun Shin; Ki Hoon Kim; Chihwan Song; Injoon Lee; Kyubum Lee; Jaewoo Kang; Yoon Kyoo Kang
Journal:  J Am Med Inform Assoc       Date:  2010 May-Jun       Impact factor: 4.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.